Chemed Inc (CHE) 145.45 $CHE
Chemed Tops Q2 Earnings on Strong Revenues, Guides Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 8:03AM CDT
Chemed Corp. (CHE) reported second-quarter 2015 adjusted earnings per share (EPS) of $1.66 from continuing operations, outshining the Zacks Consensus Estimate by 9.2%.
CHE: 145.45 (+0.71), ABAX: 48.91 (+0.58), AMED: 44.53 (+0.38), NUVA: 54.42 (+3.95)
Chemed Has Returned 16.8% Since SmarTrend Recommendation (CHE)
Comtex SmarTrend(R) - Mon Jul 27, 9:27AM CDT
SmarTrend identified an Uptrend for Chemed (NYSE:CHE) on May 11th, 2015 at $121.64. In approximately 3 months, Chemed has returned 16.85% as of today's recent price of $142.13.
CHE: 145.45 (+0.71)
Chemed posts 2Q profit
Automated Insights - Thu Jul 23, 4:58PM CDT
CINCINNATI (AP) _ Chemed Corp. (CHE) on Thursday reported second-quarter earnings of $27 million.
CHE: 145.45 (+0.71)
Chemed Reports Second-Quarter 2015 Results
Business Wire - Thu Jul 23, 3:01PM CDT
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2015, versus the comparable prior-year period, as follows:
CHE: 145.45 (+0.71)
Chemed Up 11.4% Since SmarTrend Uptrend Call (CHE)
Comtex SmarTrend(R) - Tue Jul 14, 10:06AM CDT
SmarTrend identified an Uptrend for Chemed (NYSE:CHE) on May 11th, 2015 at $121.64. In approximately 2 months, Chemed has returned 11.35% as of today's recent price of $135.45.
CHE: 145.45 (+0.71)
Chemed To Report Second-Quarter 2015 Earnings July 23, Related Conference Call To Be Held On July 24
Business Wire - Thu Jul 09, 10:30AM CDT
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2015, on Thursday, July 23, 2015, following the close of trading on the New York Stock Exchange.
CHE: 145.45 (+0.71)
Best And Worst: Mid Cap Value ETFs, Mutual Funds And Key Holdings
David Trainer - Seeking Alpha - Wed Jun 24, 8:30AM CDT
The Mid Cap Value style ranks seventh out of the 12 fund styles as detailed in our Q2'15 Style Ratings report . It gets our Dangerous rating, which is based on an aggregation of ratings of 16 ETFs and 166 mutual funds in the Mid Cap Value style. ...
CHE: 145.45 (+0.71), PXMV: 26.59 (+0.23), LNT: 59.77 (-0.77), SYLD: 31.52 (+0.22)
Chemed's Top Line Continues to Grow, Roto-Rooter Holds Key - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 23, 1:25PM CDT
On Jun 22, 2015, we updated our research report on Chemed Corporation (CHE).
CHE: 145.45 (+0.71), AMSG: 69.07 (-0.42), PMC: 34.11 (+0.36), DVA: 79.21 (+0.19)
Amedisys (AMED) Continues to Rally: Add to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 22, 1:50PM CDT
On Jun 22, 2015, we issued an updated research report on Amedisys Inc. (AMED).
CHE: 145.45 (+0.71), AMSG: 69.07 (-0.42), DVA: 79.21 (+0.19), AMED: 44.53 (+0.38)
Dividend Challengers And Near-Challengers: 34 Increases Expected In The Next 11 Weeks
David Fish - at Seeking Alpha - Wed Jun 17, 1:38AM CDT
SAFT: 56.75 (-0.14), TILE: 24.23 (+0.23), HSY: 91.90 (-0.12), BT: 74.08 (+1.09), RGA: 97.10 (+1.05), DEO: 115.18 (+1.80), CHE: 145.45 (+0.71), PAYX: 46.42 (-0.19), CBOE: 60.58 (+0.23), CMI: 128.79 (+0.79), WY: 30.11 (+0.06), WAYN: 12.75 (-0.25), SUSQ: 14.31 (+0.06), CLMS: 12.01 (-0.01), LGCY: 8.95 (-0.18), HAR: 109.23 (+1.71), MRLN: 16.22 (+0.08), BSET: 32.82 (-0.66), RECN: 15.56 (+0.29), LFUS: 92.68 (+1.61), SMG: 60.69 (+0.95), KINS: 7.65 (+0.05), EDR: 31.79 (-0.62), RAS: 5.54 (+0.18), CF: 59.25 (+0.35), MPC: 54.75 (+0.24), CVLY: 20.36 (+0.11), SBGI: 28.20 (+0.05), KLAC: 51.66 (-0.26), MRO: 21.63 (+0.43), BMTC: 29.33 (+0.27), IPHS: 51.98 (+0.66)
Is Chemed's Economic Castle Enough For Investors?
Valuentum - at Seeking Alpha - Thu Jun 11, 8:01AM CDT
CHE: 145.45 (+0.71)
Chemed Corporation to Present at the Jefferies 2015 Global Healthcare Conference
Business Wire - Thu May 28, 7:00AM CDT
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2015 Global Healthcare Conference on Wednesday, June 3, 2015, at approximately 2:30 p.m. (ET) in New York City.
CHE: 145.45 (+0.71)
Chemed declares $0.22 dividend
Seeking Alpha - at Seeking Alpha - Mon May 18, 2:16PM CDT
CHE: 145.45 (+0.71)
Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend
Business Wire - Mon May 18, 1:56PM CDT
Shareholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2015 annual shareholders' meeting. Each of the directors continues from the prior term.
CHE: 145.45 (+0.71)
Quest Diagnostics' QNatal Advanced for Prenatal Screening - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 14, 1:30PM CDT
Quest's (DGX) QNatal Advanced is a noninvasive prenatal screening test that detects common as well as rare chromosomal abnormalities in maternal blood.
CHE: 145.45 (+0.71), AMSG: 69.07 (-0.42), DGX: 73.34 (+1.22), AMED: 44.53 (+0.38)
DaVita's Inorganic Growth Impresses, MA Rate Cuts a Concern - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 11, 2:55PM CDT
We issued an updated research report on DaVita HealthCare Partners Inc. (DVA) on May 8, 2015.
CHE: 145.45 (+0.71), AMSG: 69.07 (-0.42), DVA: 79.21 (+0.19), AAC: 39.32 (-0.28)
Chemed Looks Good After Another Earnings Beat
Jonathan Weber - at Seeking Alpha - Mon May 11, 10:22AM CDT
CHE: 145.45 (+0.71)
Chemed Corporation to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
Business Wire - Fri May 08, 10:11AM CDT
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, 2015, at 1:40 PM (PDT) at the Encore at the Wynn Las Vegas.
CHE: 145.45 (+0.71)
AmSurg Beats Q1 Earnings on Solid Revenues; Guides Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 07, 12:35PM CDT
AmSurg (AMSG) delivered mixed first-quarter 2015 results beating the Zacks Consensus Estimate for earnings, but missing the mark for revenues.
CHE: 145.45 (+0.71), AMSG: 69.07 (-0.42), DGX: 73.34 (+1.22), AMED: 44.53 (+0.38)
Chemed Corporation to Present at the Deutsche Bank 40th Annual Health Care Conference
Business Wire - Mon May 04, 12:39PM CDT
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Deutsche Bank 40th Annual Health Care Conference on Thursday, May 7, 2015, at approximately 10:40 a.m. (ET) at The InterContinental Hotel in Boston, MA.
CHE: 145.45 (+0.71), DB: 33.40 (+0.16)
Chemed Tops Q2 Earnings on Strong Revenues, Guides Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 8:03AM CDT
Chemed Corp. (CHE) reported second-quarter 2015 adjusted earnings per share (EPS) of $1.66 from continuing operations, outshining the Zacks Consensus Estimate by 9.2%.
CHE: 145.45 (+0.71), ABAX: 48.91 (+0.58), AMED: 44.53 (+0.38), NUVA: 54.42 (+3.95)
Chemed Has Returned 16.8% Since SmarTrend Recommendation (CHE)
Comtex SmarTrend(R) - Mon Jul 27, 9:27AM CDT
SmarTrend identified an Uptrend for Chemed (NYSE:CHE) on May 11th, 2015 at $121.64. In approximately 3 months, Chemed has returned 16.85% as of today's recent price of $142.13.
CHE: 145.45 (+0.71)
Chemed posts 2Q profit
Automated Insights - Thu Jul 23, 4:58PM CDT
CINCINNATI (AP) _ Chemed Corp. (CHE) on Thursday reported second-quarter earnings of $27 million.
CHE: 145.45 (+0.71)
Chemed Reports Second-Quarter 2015 Results
Business Wire - Thu Jul 23, 3:01PM CDT
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2015, versus the comparable prior-year period, as follows:
CHE: 145.45 (+0.71)
Chemed Up 11.4% Since SmarTrend Uptrend Call (CHE)
Comtex SmarTrend(R) - Tue Jul 14, 10:06AM CDT
SmarTrend identified an Uptrend for Chemed (NYSE:CHE) on May 11th, 2015 at $121.64. In approximately 2 months, Chemed has returned 11.35% as of today's recent price of $135.45.
CHE: 145.45 (+0.71)
Chemed To Report Second-Quarter 2015 Earnings July 23, Related Conference Call To Be Held On July 24
Business Wire - Thu Jul 09, 10:30AM CDT
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2015, on Thursday, July 23, 2015, following the close of trading on the New York Stock Exchange.
CHE: 145.45 (+0.71)
Best And Worst: Mid Cap Value ETFs, Mutual Funds And Key Holdings
David Trainer - Seeking Alpha - Wed Jun 24, 8:30AM CDT
The Mid Cap Value style ranks seventh out of the 12 fund styles as detailed in our Q2'15 Style Ratings report . It gets our Dangerous rating, which is based on an aggregation of ratings of 16 ETFs and 166 mutual funds in the Mid Cap Value style. ...
CHE: 145.45 (+0.71), PXMV: 26.59 (+0.23), LNT: 59.77 (-0.77), SYLD: 31.52 (+0.22)
Chemed's Top Line Continues to Grow, Roto-Rooter Holds Key - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 23, 1:25PM CDT
On Jun 22, 2015, we updated our research report on Chemed Corporation (CHE).
CHE: 145.45 (+0.71), AMSG: 69.07 (-0.42), PMC: 34.11 (+0.36), DVA: 79.21 (+0.19)
Amedisys (AMED) Continues to Rally: Add to Your Portfolio? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 22, 1:50PM CDT
On Jun 22, 2015, we issued an updated research report on Amedisys Inc. (AMED).
CHE: 145.45 (+0.71), AMSG: 69.07 (-0.42), DVA: 79.21 (+0.19), AMED: 44.53 (+0.38)
Dividend Challengers And Near-Challengers: 34 Increases Expected In The Next 11 Weeks
David Fish - at Seeking Alpha - Wed Jun 17, 1:38AM CDT
SAFT: 56.75 (-0.14), TILE: 24.23 (+0.23), HSY: 91.90 (-0.12), BT: 74.08 (+1.09), RGA: 97.10 (+1.05), DEO: 115.18 (+1.80), CHE: 145.45 (+0.71), PAYX: 46.42 (-0.19), CBOE: 60.58 (+0.23), CMI: 128.79 (+0.79), WY: 30.11 (+0.06), WAYN: 12.75 (-0.25), SUSQ: 14.31 (+0.06), CLMS: 12.01 (-0.01), LGCY: 8.95 (-0.18), HAR: 109.23 (+1.71), MRLN: 16.22 (+0.08), BSET: 32.82 (-0.66), RECN: 15.56 (+0.29), LFUS: 92.68 (+1.61), SMG: 60.69 (+0.95), KINS: 7.65 (+0.05), EDR: 31.79 (-0.62), RAS: 5.54 (+0.18), CF: 59.25 (+0.35), MPC: 54.75 (+0.24), CVLY: 20.36 (+0.11), SBGI: 28.20 (+0.05), KLAC: 51.66 (-0.26), MRO: 21.63 (+0.43), BMTC: 29.33 (+0.27), IPHS: 51.98 (+0.66)
Is Chemed's Economic Castle Enough For Investors?
Valuentum - at Seeking Alpha - Thu Jun 11, 8:01AM CDT
CHE: 145.45 (+0.71)
Chemed Corporation to Present at the Jefferies 2015 Global Healthcare Conference
Business Wire - Thu May 28, 7:00AM CDT
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2015 Global Healthcare Conference on Wednesday, June 3, 2015, at approximately 2:30 p.m. (ET) in New York City.
CHE: 145.45 (+0.71)
Chemed declares $0.22 dividend
Seeking Alpha - at Seeking Alpha - Mon May 18, 2:16PM CDT
CHE: 145.45 (+0.71)
Chemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend
Business Wire - Mon May 18, 1:56PM CDT
Shareholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company's 2015 annual shareholders' meeting. Each of the directors continues from the prior term.
CHE: 145.45 (+0.71)
Quest Diagnostics' QNatal Advanced for Prenatal Screening - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 14, 1:30PM CDT
Quest's (DGX) QNatal Advanced is a noninvasive prenatal screening test that detects common as well as rare chromosomal abnormalities in maternal blood.
CHE: 145.45 (+0.71), AMSG: 69.07 (-0.42), DGX: 73.34 (+1.22), AMED: 44.53 (+0.38)
DaVita's Inorganic Growth Impresses, MA Rate Cuts a Concern - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 11, 2:55PM CDT
We issued an updated research report on DaVita HealthCare Partners Inc. (DVA) on May 8, 2015.
CHE: 145.45 (+0.71), AMSG: 69.07 (-0.42), DVA: 79.21 (+0.19), AAC: 39.32 (-0.28)
Chemed Looks Good After Another Earnings Beat
Jonathan Weber - at Seeking Alpha - Mon May 11, 10:22AM CDT
CHE: 145.45 (+0.71)
Chemed Corporation to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
Business Wire - Fri May 08, 10:11AM CDT
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2015 Health Care Conference on Tuesday, May 12, 2015, at 1:40 PM (PDT) at the Encore at the Wynn Las Vegas.
CHE: 145.45 (+0.71)
AmSurg Beats Q1 Earnings on Solid Revenues; Guides Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 07, 12:35PM CDT
AmSurg (AMSG) delivered mixed first-quarter 2015 results beating the Zacks Consensus Estimate for earnings, but missing the mark for revenues.
CHE: 145.45 (+0.71), AMSG: 69.07 (-0.42), DGX: 73.34 (+1.22), AMED: 44.53 (+0.38)
Chemed Corporation to Present at the Deutsche Bank 40th Annual Health Care Conference
Business Wire - Mon May 04, 12:39PM CDT
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Deutsche Bank 40th Annual Health Care Conference on Thursday, May 7, 2015, at approximately 10:40 a.m. (ET) at The InterContinental Hotel in Boston, MA.
CHE: 145.45 (+0.71), DB: 33.40 (+0.16)
